Haytham Tawfik

47PUBLICATIONS
95CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Sep 25, 2026
Discovery of tricyclic benzo[4,5]imidazo[2,1-b]thiazole-3-hydroxyindolin-2-one hybrids as selective MAO-B and cholinesterase inhibitors.

|Sep 15, 2026
Development of isonicotinoyl-azole hybrids as potential InhA inhibitors for anti-tubercular activity.

|Sep 10, 2026
Harnessing coumarin privilege to achieve potency and selectivity: hypoxia-targeted alkyl coumarin-tethered phenyl quinazolinones as dual hCA IX/HSP90α inhibitors with chemosensitizing activity.

|Sep 02, 2026
Design and synthesis of 1,3,4-oxadiazole-tethered N-substituted isatin hybrids as SARS-CoV-2 main protease inhibitors: biological evaluation, kinetic investigation, and in silico studies.

|Aug 18, 2026
Quinazolinone-triazole hybrids as multi-target-directed ligands for Alzheimer's disease: discovery of potent and selective MAO-B inhibitors with cholinesterase modulating activity.

|Aug 10, 2026
Targeting CDK-2 With Novel Indole-Pyrazole Hybrids: Discovery of Potent Anticancer Agents Supported by Mechanistic and In Silico Studies.

Pageof 8

Frequent Collaborators

27 joint publications

Wagdy M Eldehna

15 joint publications

Moataz Shaldam

12 joint publications

Claudiu T Supuran

7 joint publications

Mohamed S Nafie